Form D · Other Health Care
SlipChip Corp
Chicago, IL · CIK 0001584751
Offering snapshot reported Oct 17, 2017 · SEC filing
- Reported sold
- $28.9M Offering amount: $30M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2017 | Initial | $28,944,628 | No comparison | 9 | SEC filing |
| Mar 6, 2015 | Initial | $26,550,002 | No comparison | 6 | SEC filing |
| Aug 20, 2013 | Initial | $4,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-296844
Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof.
Source: Form D, filed Oct 17, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Felix Baker | Director |
| Brian Coe | Director, Executive |
| Rustem Ismagilov | Director |
| Matt Posard | Director |
| Randy Scott | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
118 N. Clinton Street Suite 205
Chicago, IL, 60661
Chicago, IL, 60661